发明名称 SPECIFIC HUMAN ANTIBODIES FOR SELECTIVE CANCER THERAPY
摘要 The present invention is directed to a peptide or polypeptide comprising an Fv molecule, a construct thereof, a fragment of either, or a construct of a fragment having enhanced binding characteristics so as to bind selectively and/or specifically to a target cell in favor of other cells, wherein the binding selectivity or specificity is primarily determined by a first hypervariable region, and wherein the Fv is a scFv or a dsFv, and optionally having one or more tags. The enhanced binding is directed to a substantially exposed and/or over-expressed binding site on or in a target comprising a cell in favor of other cells on or in which the binding site is not substantially available and/or expressed. The invention is further directed to a method for isolating such peptides and polypeptides from a phage display library and to the nucleic acid molecules encoding them. The invention provides for a pharmaceutical composition comprising the peptide or polypeptide and kits for diagnosis and treatment of disease, specifically cancer, most specifically acute myeloid leukemia.
申请公布号 KR20030091952(A) 申请公布日期 2003.12.03
申请号 KR20037008885 申请日期 2003.06.30
申请人 发明人
分类号 C07K16/18;C12N15/09;A61K38/00;A61K38/02;A61K39/395;A61K51/00;A61P35/00;C07K14/47;C12N15/13;C12P21/02;C12P21/08;C12Q1/02;C12Q1/68 主分类号 C07K16/18
代理机构 代理人
主权项
地址